<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2000
BASF AKTIENGESELLSCHAFT
(Exact name of Registrant as Specified in its Charter)
BASF CORPORATION
(Translation of Registrant's name into English)
Carl Bosch Strasse 38, LUDWIGSHAFEN, GERMANY 67056
(Address of Principal Executive Offices)
Indicate by check mark whether the Registrant files or will file annual
reports under cover Form 20-F or Form 40-F
Form 20-F X Form 40-F
--- ----
Indicate by check mark whether the Registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes No X
----- ------
If "Yes" is marked, indicate below the file number assigned to the
Registrant in connection with Rule 12g3-2(b): 82- .
---------
Page 1
<PAGE> 2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Current Report to be signed on its behalf by
the undersigned, thereunto duly authorized.
BASF Aktiengesellschaft
Date: December 19, 2000 By: /s/ Kurt Leidner
---------------------------------
Name: Kurt Leidner
Title: Director Communications
Ludwigshafen Site
By: /s/ Felix Gress
---------------------------------
Name: Felix Gress
Title: Director Communications
BASF Group
<PAGE> 3
EXHIBIT No. EXHIBIT
99.1 Press Release P576e
99.2 Press Release P570e
99.3 Press Release P569e
99.4 Press Release P568e
99.5 Press Release P559e
99.6 Press Release BASF Pharma dated December 4, 2000
99.7 Press Release P525e
99.8 Press Release P523e
99.9 Press Release P519e
